日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IGSF11-VISTA is a critical and targetable immune checkpoint axis in diffuse midline glioma.

IGSF11-VISTA 是弥漫性中线胶质瘤中一个关键且可靶向的免疫检查点轴。

Collot Raphaël, Ruiz-Moreno Cristian, Honhoff Celina, van den Broek Thijs J M, Wezenaar Amber K L, Kloosterman Daan J, Ariese Hendrikus C R, Johnson Hannah, Vervoort Britt M T, Jeiroshi Amal, Bunt Jens, van Ineveld Ravian L, Bokobza Emma, Rebel Heggert G, Te Pas Brigit M, Ringnalda Femke C A, van de Wetering Marc, Robe Pierre A, Kool Marcel, Cochran Jennifer R, Kranendonk Mariëtte E G, van Vuurden Dannis G, Hulleman Esther, Wehrens Ellen J, Zomer Anoek, Stunnenberg Hendrik G, Rios Anne C

De novo H3.3K27M-altered diffuse midline glioma in human brainstem organoids to dissect GD2 CAR T cell function.

在人脑干类器官中构建新生 H3.3K27M 改变的弥漫性中线胶质瘤,以解析 GD2 CAR T 细胞功能。

Bessler Nils, Wezenaar Amber K L, Ariese Hendrikus C R, Honhoff Celina, Dommann Noëlle, Wehrens Ellen J, Ruiz Moreno Cristian, van den Broek Thijs J M, Collot Raphaël V U, Kloosterman Daan J, Keramati Farid, Roosen Mieke, de Blank Sam, van Vliet Esmée, Barrera Román Mario, Gatti Lucrezia C D E, Ertürk Ali, Kuball Jürgen, Sebestyén Zsolt, Kool Marcel, Patrizi Sara, Miele Evelina, Künkele Annette, Kranendonk Mariëtte E G, Cornel Annelisa M, Nierkens Stefan, Mayer Christian, Stunnenberg Hendrik G, Alemany Anna, Alieva Maria, Rios Anne C

Rh(III)-Catalyzed C(sp(2))–H Activation/Annulation for the Construction of Pyrrolo[3,4‑b]indolediones and Their Application as Fluorescent Chemosensors

Rh(III)催化的C(sp(2))–H活化/环化反应构建吡咯并[3,4-b]吲哚二酮及其在荧光化学传感器中的应用

Yuen, Lik Hang; Franzini, Raphael M; Wang, Shenliang; Crisalli, Pete; Singh, Vijay; Jiang, Wei; Kool, Eric T; Akhtar, Muhammad Saeed; Aslam, Mohammad; Mohandoss, Sonaimuthu; Lim, Hee Nam; Lee, Yong Rok

Author Correction: Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumors

作者更正:DNA损伤修复缺陷会导致小鼠和人类肿瘤中频繁发生灾难性的基因组事件。

Ratnaparkhe, Manasi; Wong, John K L; Wei, Pei-Chi; Hlevnjak, Mario; Kolb, Thorsten; Simovic, Milena; Haag, Daniel; Paul, Yashna; Devens, Frauke; Northcott, Paul; Jones, David T W; Kool, Marcel; Jauch, Anna; Pastorczak, Agata; Mlynarski, Wojciech; Korshunov, Andrey; Kumar, Rajiv; Downing, Susanna M; Pfister, Stefan M; Zapatka, Marc; McKinnon, Peter J; Alt, Frederick W; Lichter, Peter; Ernst, Aurélie

CAR T cells targeting the glycoprotein GD2 show potent antitumor efficacy in high-risk ependymoma models

靶向糖蛋白GD2的CAR-T细胞在高危室管膜瘤模型中显示出强大的抗肿瘤疗效

Tallon-Cobos, Antonio Carlos; Vazaios, Konstantinos; Waranecki, Piotr; van Hoesel, Marliek; Cornel, Annelisa; Schwalm, Benjamin; Mack, Norman; de Boed, Ella; van der Lugt, Jasper; Nierkens, Stefan; Kool, Marcel; Hoving, Eelco W; Metselaar, Dennis S; Hulleman, Esther

Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries

基于前瞻性试验 E-HIT2000 和后续注册研究,开发儿童颅内室管膜瘤的高级风险分层模型

von Hoff, Katja; Obrecht-Sturm, Denise; Ghasemi, David R; Wenning, Janna; Mynarek, Martin; Gerber, Nicolas U; Benesch, Martin; Juhnke, Björn O; Bison, Brigitte; Warmuth-Metz, Monika; Timmermann, Beate; Faldum, Andreas; Tippelt, Stephan; Fleischhack, Gudrun; Grotzer, Michael; Hernáiz Driever, Pablo; Beilken, Andreas; Ebinger, Martin; Graf, Norbert; Frühwald, Michael C; Schmid, Irene; Slavc, Irene; Koch, Arend; Bergmann, Markus; Hagel, Christian; Coras, Roland; Blümcke, Ingmar; Reifenberger, Guido; Felsberg, Jörg; Keyvani, Kathy; Harter, Patrick N; Prinz, Marco; Staszewski, Ori; Acker, Till; Stadelmann-Nessler, Christine; Hartmann, Christian; von Deimling, Andreas; Sommer, Clemens; Hasselblatt, Martin; Riemenschneider, Markus J; Monoranu, Camelia-Maria; Rushing, Elisabeth; Haberler, Christine; Kool, Marcel; Sill, Martin; Pfister, Stefan M; Schüller, Ulrich; Pietsch, Torsten; Kortmann, Rolf D; Kwiecien, Robert; Witt, Hendrik; Pajtler, Kristian W; Rutkowski, Stefan

Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder Analysis

儿童恶性肿瘤中ATR抑制剂的研发路径:一项ACCELERATE多方利益相关者分析

Gatz, Susanne A; Glade-Bender, Julia; Pearson, Andrew D J; Ortiz, Michael V; Bernardi, Ronald; Chesler, Lou; Clifford, Steve; Cohen-Gogo, Sarah; De La Cuesta, Esther; de Rojas, Teresa; Durinck, Kaat; Federico, Sara; Fox, Elizabeth; George, Sally; Gounaris, Ioannis; Henssen, Anton George; Irwin, Meredith; Kool, Marcel; Lau, Alan; Nysom, Karsten; Pappo, Alberto; Pennock, Gregory K; Pfister, Stefan M; Scobie, Nicole; Slotkin, Emily K; Smith, Malcolm; Speleman, Frank; Stewart, Elizabeth A; Weigel, Brenda J; Vassal, Gilles

Bothrops venom variation drives niche-specific pharmacology through Ca(2+) signalling and membrane damage

矛头蝮蛇毒液的变异通过钙离子信号传导和膜损伤驱动其在特定生态位中的药理作用。

Bourke, Lachlan A; Slagboom, Julien; Waller, Matthew A; Neely, G Gregory; Kool, Jeroen; Cardoso, Fernanda C

Preclinical drug screen identifies WEE1 inhibitor and vinca alkaloid as a combination treatment concept for Li-Fraumeni syndrome medulloblastoma.

临床前药物筛选发现 WEE1 抑制剂和长春花生物碱可作为李-弗劳梅尼综合征髓母细胞瘤的联合治疗方案。

Kolodziejczak Anna S, Selt Florian, Peterziel Heike, Jamaladdin Nora, Mack Norman, Maaß Kendra, Meulenbroeks Chris, Sigaud Romain, Herold-Mende Christel, El Damaty Ahmed, Burhenne Jürgen, Ohmura Shunya, Holland-Letz Tim, Kutscher Lena M, Ernst Aurélie, Wei Pei-Chi, Grünewald Thomas G P, Oehme Ina, Kool Marcel, Jones David T W, Pajtler Kristian W, Kratz Christian P, Pfister Stefan M, Witt Olaf, Milde Till

Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach.

通过多组学方法揭示室管膜瘤组特异性血脑屏障差异。

Sundheimer Julia K, Benzel Julia, Federico Aniello, Volz Stefanie, Knoll Maximilian, Statz Britta, Zheng Tuyu, Kmiecik Szymon W, Burhenne Jürgen, Bajraktari-Sylejmani Gzona, Scheuermann Sophia, King Anke, Müller Torsten, Hübner Jens-Martin, Kalxdorf Mathias, Peterziel Heike, Oehme Ina, Krijgsveld Jeroen, Seitz Christian M, Kool Marcel, Pfister Stefan M, Pajtler Kristian W, Maaß Kendra K